Latigo Biotherapeutics
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Latigo Biotherapeutics
- Company name
- Latigo Biotherapeutics
- Organisation type
- Industry
- Registered legal name
- Latigo Biotherapeutics, Inc.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0002056611
Related records
Trials (8)
- A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants
- A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants
- A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants
- An Efficacy and Safety Study of LTG-001 Following Abdominoplasty
- Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults
- Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults
- Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants
- This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars